| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to a compound of structural formula I n which can be used for protecting cardiomyocytes or for preventing or treating a disease or a disorder related to cardiomyocyte apoptosis. In formula I A represents =S, -SR 4 or =O, X represents F, Cl, Br or I, R 1 represents phenyl, R 2 and R 3 are connected to form morpholine, and R 4 represents C 1 -C 6 -alkyl. n EFFECT: invention refers to using the compound for producing the therapeutic agent for protecting cardiomyocytes or for preventing or treating a disease or a disorder related to cardiomyocyte apoptosis, and to the method for producing the above compounds. n 8 cl, 2 tbl, 2 ex |